CAG repeat disorder models and human neuropathology: similarities and differences.

Area of Science:

• Neuroscience
• Genetics
• Pathology

Background:

• CAG repeat diseases are a group of hereditary neurodegenerative disorders.
• These disorders are caused by the expansion of a polyglutamine tract in specific proteins.
• Examples include Huntington's disease (HD), spinocerebellar ataxias (SCA1-17), and others.

Purpose of the Study:

• To investigate the common pathological changes in the brains of patients with CAG repeat diseases.
• To compare human neuropathology with findings from mouse models of these diseases.
• To understand the relationship between protein accumulation, neuronal changes, and clinical onset.

Main Methods:

• Analysis of human brain tissue from patients with various CAG repeat diseases.
• Review and comparison of existing mouse models for CAG repeat diseases.
• Examination of neuropathological features such as intranuclear inclusions and neuronal loss.

Main Results:

• Human brains with CAG repeat diseases exhibit shared polyglutamine-related changes, including intranuclear inclusions, in both neuronal nuclei and cytoplasm.
• These pathological changes are often distributed beyond areas of significant neuronal loss, indicating wider neuronal involvement.
• Mouse models, while showing some polyglutamine-related changes, do not fully replicate human neuropathology, particularly specific patterns of neuronal loss.
• Clinical onset in these diseases appears correlated with the intranuclear accumulation of mutant proteins rather than overt neuronal cell death.

Conclusions:

• CAG repeat diseases share common pathological hallmarks beyond specific disease phenotypes.
• Current mouse models incompletely recapitulate human neuropathology, limiting their predictive power.
• Intranuclear accumulation of mutant proteins is a critical factor in the pathogenesis and clinical onset of CAG repeat diseases.